Tursi James Patrick 4
4 · ANTARES PHARMA, INC. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
Tursi James Patrick
EVP, Chief Medical Officer
Transactions
- Award
Common Stock
2019-06-13$2.92/sh+45,205$131,999→ 45,205 total - Award
Stock Option (right to buy)
2019-06-13+90,788→ 90,788 totalExercise: $2.92Exp: 2029-06-13→ Common Stock (90,788 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F3]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.